PreciHealth

What PreciHealth does

Preci-Health SA is a Swiss-based medtech and AI innovator founded in 2017 and headquartered in Neuchâtel, Switzerland. The company develops needle-free blood collection technology built on a patented "Piece and Draw" mechanism invented by CTO and co-founder Lucien Vouillamoz. Its core product, ezdraw, is positioned as the first capillary blood sampler to support standard-sized multi-tube extraction, collecting 1.5–4ml of blood in two standard vacutainers from a single high-volume draw, and is designed to function in low or no gravity environments (validated aboard the Polaris Dawn mission in September 2024). The device is intended for both assisted clinical use and self-administration.

The company complements ezdraw with PreciPal, an AI-driven companion application that uses computer vision and facial recognition for biometric patient authentication, real-time procedural guidance, and procedure certification without requiring Wi-Fi or Bluetooth connectivity. Additional products include a line of micro auto-injectors (130 mm³ to 30 mm³ dosage range) and a self-vaccination system for location-agnostic vaccine delivery. The product portfolio targets decentralized healthcare across professional settings (hospitals, clinics, laboratories, pharmacies) and home-based self-administration for chronic disease monitoring and remote diagnostics.

Preci-Health is pre-commercial: the ezdraw device is explicitly labeled "Not for sale. Investigational Use Only." Revenue mechanics, once launched, are expected to combine single-use hardware sales (clinical investigations and post-launch commercial), licensing of the PreciPal app to third-party solution providers, and clinical validation services. Go-to-market is enterprise-led, anchored by a strategic investment and clinical collaboration with Intermountain Health (385 clinics and 33 hospitals) for the FDA pathway, supplemented by industry advisors including former Labcorp Drug Development CEO Paul Kirchgraber. The company secured CE Mark MDR certification in January 2026 under EU Medical Device Regulation 2017/745 and is preparing for a 2026 commercial launch.

Name

PreciHealth

Legal name

Preci-Health SA

Website

https://precihealth.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Preci-Health SA is a Swiss medtech company developing the needle-free ezdraw capillary blood sampler and AI-guided PreciPal companion app, targeting hospitals, clinics, laboratories, and home-based self-administered use ahead of a 2026 commercial launch following CE Mark MDR certification.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Auto-Injectors (Disposable & Reusable) (HLAHAIAB)

akta.pro secondary industries

Needle-Free Injection Systems (Jet Injectors/Microneedle Patches) (HLAHAIAD), Vaccine Delivery & Administration Systems (needle-free, microneedle patches, intranasal/oral) (HLAAAEAF), Prefilled Syringes & Safety Syringes (HLAHAIAA)

Keywords

• Needle-free blood collection
• Capillary blood sampling
• Medical device innovation
• Decentralized diagnostics
• Micro auto-injectors

Headquarters

HQ city

Neuchâtel

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. ezdraw Blood Sampler Device Sales: Single-use needle-free blood collection devices sold to healthcare providers, clinics, laboratories, and pharmacies for clinical use. Device is currently available only for clinical investigations.
2. PreciPal Companion App Licensing: AI-driven companion application with biometric authentication. Technology can be licensed to external solution providers. Includes HMO database connectivity.
3. Clinical Validation Services: Professional services supporting FDA approval process including IRB-approved studies and clinical validation partnerships with healthcare systems.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

PreciHealth develops and manufactures needle-free medical devices for decentralized blood collection and injection. Its flagship product, the ezdraw™ capillary blood sampler, enables standard-sized multi-tube extraction (1.5–4 ml) in a single draw compatible with standard vacutainers. The companion PreciPal app uses computer vision and facial recognition to authenticate patients and provide real-time procedural guidance without Wi-Fi or Bluetooth. The portfolio also includes micro-dosage auto-injectors and a self-vaccination system.

Product overview

PreciHealth offers a portfolio of decentralized healthcare solutions centered on needle-free blood collection and injection technology. The core product is ezdrawTM, a multi-tube blood sampler that works with standard vacutainers for seamless lab integration. This is complemented by PreciPal, an AI-driven companion app providing authentication and real-time guidance. Additional products include Micro Auto-Injectors for micro-dosage injection and a Self-Vaccination System for location-agnostic vaccine delivery. The platform enables both assisted and self-administered blood collection and injection solutions for at-clinic and at-home use.

Differentiator

Problem solved

Functional benefit

Brands

• ezdrawTM: The first capillary blood sampler to support standard-sized multi-tube extraction. Needle-free blood collection device designed for both at-clinic and at-home use.
• PreciPal
• Micro Auto-Injectors
• Self-Vaccination System

Products and services

• ezdraw™ Blood Sampler The first capillary blood sampler to support standard-sized multi-tube extraction, ezdraw™ is a needle-free, single-use device that collects 1.5–4 ml of blood in two tubes from a single draw and is compatible with standard vacutainers for seamless lab automation integration. Designed for both assisted and self-administered use in clinical settings.
• PreciPal Companion App

Quantifiable outcome

• First-ever specialized techniques (flow cytometry and viscometry) used on fresh blood from space
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and flagship.

• Intermountain HealthcoreStrategic or Co-development Partner · 18 August 2025Strategic investment and clinical collaboration with nonprofit healthcare system based in Utah, USA. Intermountain Health operates 33 hospitals and 385 clinics across the Intermountain West. Supporting Preci-Health through FDA approval process including IRB-approved studies in northern and central Utah, and evaluating ezdraw integration for clinic-based preventive health and home-based remote diagnostics.
• Paul Kirchgraber, MD, MBAcoreOthers · 13 August 2025Former CEO of Covance and Labcorp Drug Development ($6B division). Brings decades of executive experience in clinical diagnostics and laboratory services. Will help drive Preci-Health's strategic and commercial growth.
• Ottawa Hospital Research Institute (OHRI)coreStrategic or Co-development Partner · 10 September 2024Collaboration with Dr. Guy Trudel on blood collection experiments aboard Polaris Dawn mission. ezdraw was used to collect blood samples from all four crew members for the Anemia protocol - only the second trial ever to analyze fresh blood from space. Specialized techniques including flow cytometry and viscometry were used on fresh blood from space for the first time.
• Top-10 Pharmaceutical CompanyflagshipStrategic or Co-development PartnerPrior validation and collaboration with global pharmaceutical leader for validation of ezdraw blood collection technology.
• Two Leading European Diagnostic LaboratoriesflagshipStrategic or Co-development PartnerPrior collaborations for validation of ezdraw blood collection technology with two of Europe's leading diagnostic laboratories.

Scale indicators5 records

Recent moves6 records

Expansion highlights7 records

Direct peers

• Tasso: US-based developer of OnDemand and Tasso-Mini capillary blood collection devices designed for virtually painless, self-administered sample collection. Direct overlap with PreciHealth's ezdraw in needle-free capillary blood sampling for decentralized diagnostics.
• Yourbio Health: Developer of the TAP (Touch Activated Phlebotomy) device, a needle-free blood collection platform. Directly comparable to PreciHealth's ezdraw as a needle-free capillary sampling solution targeting decentralized clinical trials and home diagnostics.
• Velano Vascular: Maker of needle-free blood draw technology designed to reduce multiple needlesticks during inpatient hospital blood collection. Comparable to PreciHealth in addressing patient discomfort and workflow efficiency in venipuncture.
• Drawbridge Health: Developer of the OneDraw device for virtually painless, needle-free capillary blood collection targeted at home and clinical use. Overlaps directly with PreciHealth's self-administered, AI-guided blood sampling model.
• PharmaJet: Developer of needle-free jet injection systems (Tropis, Stratis) used for vaccine and therapeutic delivery. Comparable to PreciHealth's Micro Auto-Injectors and Self-Vaccination System in needle-free delivery technology.

Broad incumbents

• Owen Mumford: Established UK-based manufacturer of auto-injectors, pen injectors, and capillary blood sampling devices. Overlaps with PreciHealth's Micro Auto-Injectors product line and blood collection category as a larger, broader-portfolio incumbent.
• Ypsomed: Swiss-headquartered leader in self-injection systems and pen injectors for pharma partners. Comparable to PreciHealth's Micro Auto-Injectors and Self-Vaccination System as a larger established player in the drug delivery space.
• Becton, Dickinson and Company (BD): Global incumbent dominating the vacutainer, capillary blood collection, and injection device markets that PreciHealth's ezdraw and Micro Auto-Injectors target. Provides the ecosystem standard (BD Vacutainer) that PreciHealth has explicitly designed around for compatibility.
• West Pharmaceutical Services: Global leader in injectable drug containment and delivery, including auto-injector and wearable injector components. Comparable to PreciHealth's Micro Auto-Injector business as a broader delivery-platform incumbent serving pharma partners.

Emerging players

• Enable Injections: Developer of the enFuse wearable large-volume injector platform for subcutaneous delivery of biologics. Comparable to PreciHealth's Micro Auto-Injectors and Self-Vaccination System in next-generation, patient-friendly injection technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/precihealth/about

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PreciHealth